Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Impact of breast cancer grade discordance on prediction of outcome.

Rakha EA, Aleskandarany MA, Toss MS, Mongan NP, ElSayed ME, Green AR, Ellis IO, Dalton LW.

Histopathology. 2018 Dec;73(6):904-915. doi: 10.1111/his.13709. Epub 2018 Sep 19.

PMID:
29999192
2.

Breast cancer histologic grading using digital microscopy: concordance and outcome association.

Rakha EA, Aleskandarani M, Toss MS, Green AR, Ball G, Ellis IO, Dalton LW.

J Clin Pathol. 2018 Aug;71(8):680-686. doi: 10.1136/jclinpath-2017-204979. Epub 2018 Mar 13.

PMID:
29535212
3.

Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192).

Page DL, Gray R, Allred DC, Dressler LG, Hatfield AK, Martino S, Robert NJ, Wood WC.

Am J Clin Oncol. 2001 Feb;24(1):10-8.

PMID:
11232942
4.

Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.

Pinto AE, Pereira T, Silva GL, André S.

Breast. 2015 Aug;24(4):449-55. doi: 10.1016/j.breast.2015.04.004. Epub 2015 Apr 25.

PMID:
25920680
5.

Histological grading of invasive breast carcinoma--a simplification of existing methods in a large conservation series with long-term follow-up.

Thomas JS, Kerr GR, Jack WJ, Campbell F, McKay L, Pedersen HC, Kunkler IH, Cameron DA, Chetty U, Bartlett JM.

Histopathology. 2009 Dec;55(6):724-31. doi: 10.1111/j.1365-2559.2009.03429.x.

PMID:
19845790
6.

Determining breast cancer histological grade from RNA-sequencing data.

Wang M, Klevebring D, Lindberg J, Czene K, Grönberg H, Rantalainen M.

Breast Cancer Res. 2016 May 10;18(1):48. doi: 10.1186/s13058-016-0710-8.

7.

Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome.

Ho SK, Thike AA, Cheok PY, Tse GM, Tan PH.

Histopathology. 2013 Sep;63(3):393-406. doi: 10.1111/his.12177. Epub 2013 Jun 18.

PMID:
23772632
9.

[Lobular invasive breast cancer prognostic factors: About 940 patients].

Jauffret C, Houvenaeghel G, Classe JM, Garbay JR, Giard S, Charitansky H, Cohen M, Bélichard C, Faure C, Darai É, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Martino M, Coutant C, Dravet F, Chauvet MP, Chéreau Ewald E, Penault-Llorca F, Goncalves A, Lambaudie É.

Gynecol Obstet Fertil. 2015 Nov;43(11):712-7. doi: 10.1016/j.gyobfe.2015.09.007. Epub 2015 Oct 16. French.

PMID:
26482833
10.

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.

Rakha EA, El-Rehim DA, Paish C, Green AR, Lee AH, Robertson JF, Blamey RW, Macmillan D, Ellis IO.

Eur J Cancer. 2006 Dec;42(18):3149-56. Epub 2006 Oct 19.

PMID:
17055256
11.

Prognostic relevance of histological grade and its components in node-negative breast cancer patients.

Volpi A, Bacci F, Paradiso A, Saragoni L, Scarpi E, Ricci M, Aldi M, Bianchi S, Muretto P, Nuzzo F, Simone G, Mangia A, Schittulli F, Amadori D.

Mod Pathol. 2004 Sep;17(9):1038-44.

12.
13.

Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer.

Horita K, Yamaguchi A, Hirose K, Ishida M, Noriki S, Imamura Y, Fukuda M.

Eur J Histochem. 2001;45(1):73-84.

PMID:
11411868
14.

p-mTOR expression is associated with better prognosis in luminal breast carcinoma.

Beca F, Andre R, Martins DS, Bilhim T, Martins D, Schmitt F.

J Clin Pathol. 2014 Nov;67(11):961-7. doi: 10.1136/jclinpath-2014-202320. Epub 2014 Jul 22.

PMID:
25053543
15.

Comparison of estrogen receptor, progesterone receptor and HER2 results in concurrent ipsilateral samples with invasive breast carcinoma: a retrospective study of 246 biopsies from 119 patients.

Singh K, Wang Y, Marketkar S, Kalife ET, Steinhoff MM.

Hum Pathol. 2017 Jul;65:123-132. doi: 10.1016/j.humpath.2017.04.016. Epub 2017 Apr 27.

PMID:
28457730
16.

The prognostic value of androgen receptors in breast cancer subtypes.

Kraby MR, Valla M, Opdahl S, Haugen OA, Sawicka JE, Engstrøm MJ, Bofin AM.

Breast Cancer Res Treat. 2018 Nov;172(2):283-296. doi: 10.1007/s10549-018-4904-x. Epub 2018 Aug 14.

PMID:
30109519
17.

Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women.

Agboola AJ, Musa AA, Wanangwa N, Abdel-Fatah T, Nolan CC, Ayoade BA, Oyebadejo TY, Banjo AA, Deji-Agboola AM, Rakha EA, Green AR, Ellis IO.

Breast Cancer Res Treat. 2012 Sep;135(2):555-69. doi: 10.1007/s10549-012-2173-7. Epub 2012 Jul 29.

PMID:
22842985
18.

Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer.

Rakha EA, Agarwal D, Green AR, Ashankyty I, Ellis IO, Ball G, Alaskandarany MA.

Histopathology. 2017 Mar;70(4):622-631. doi: 10.1111/his.13108. Epub 2016 Dec 28.

PMID:
27782306
19.

[Prognostic values of grading system for lymph vessel tumor emboli in patients with invasive breast carcinomas of no special type].

Yue M, Li F, Deng HY, Zhang LL, Liu YP.

Zhonghua Zhong Liu Za Zhi. 2017 Oct 23;39(10):754-758. doi: 10.3760/cma.j.issn.0253-3766.2017.10.007. Chinese.

PMID:
29061019
20.

Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic.

Nascimento AF, Raut CP, Fletcher CD.

Am J Surg Pathol. 2008 Dec;32(12):1896-904. doi: 10.1097/PAS.0b013e318176dbc7.

PMID:
18813119

Supplemental Content

Support Center